BioCorRx Inc. (BICX)

$2

0.00 (0.00%)
Rating:
Recommendation:
-
Symbol BICX
Price $2
Beta 0.761
Volume Avg. 0.00M
Market Cap 15.257M
Shares () -
52 Week Range 1.0-5.0
1y Target Est -
DCF Unlevered BICX DCF ->
DCF Levered BICX LDCF ->
ROE 62.70% Strong Buy
ROA -538.36% Strong Sell
Operating Margin -
Debt / Equity -111.38% Sell
P/E -2.90 Sell
P/B -1.99 Sell
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest BICX news


Ms. Lourdes Felix
Healthcare
Medical Care Facilities
Other OTC

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.